Related references
Note: Only part of the references are listed.Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Immune factors associated with the pathological and therapeutic effects of preoperative chemotherapy in patients with breast cancer
Ryungsa Kim et al.
TRANSLATIONAL ONCOLOGY (2021)
The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis
Weijuan Cao et al.
BMC GASTROENTEROLOGY (2020)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Blockade of Platelets Using Tumor-Specific NO-Releasing Nanoparticles Prevents Tumor Metastasis and Reverses Tumor Immunosuppression
Yan Xu et al.
ACS NANO (2020)
Preoperative Platelet to Lymphocyte Ratio as a Prognostic Factor for Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
Romualdas Riauka et al.
DIGESTIVE SURGERY (2020)
The Immune Nature of Platelets Revisited
Amal Maouia et al.
TRANSFUSION MEDICINE REVIEWS (2020)
Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes
Silvia Pesce et al.
CANCERS (2020)
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Alexander B. Zaslavsky et al.
SCIENTIFIC REPORTS (2020)
Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study
Linbin Lu et al.
BMJ OPEN (2020)
Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells: Implications for the metastatic cascade
Christopher D. Cluxton et al.
PLOS ONE (2019)
Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL
Kim L. Clar et al.
CANCERS (2019)
Tumor-Specific Silencing of Tissue Factor Suppresses Metastasis and Prevents Cancer-Associated Hypercoagulability
Shaoli Liu et al.
NANO LETTERS (2019)
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
Silvia Pesce et al.
FRONTIERS IN IMMUNOLOGY (2019)
Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management
Jennifer N. Brudno et al.
BLOOD REVIEWS (2019)
Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Huilin Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells
Stefanie Maurer et al.
ONCOIMMUNOLOGY (2018)
Molecular mechanisms of platelet activation and aggregation induced by breast cancer cells
Marta Zara et al.
CELLULAR SIGNALLING (2018)
Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer
Alison J. Gareau et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
The prognostic role of pretreatment thrombocytosis in gastric cancer A systematic review and meta-analysis
Chen Yang et al.
MEDICINE (2018)
Inhibition of platelet function using liposomal nanoparticles blocks tumor metastasis
Yinlong Zhang et al.
THERANOSTICS (2017)
Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer
Qianghua Hu et al.
CLINICAL CANCER RESEARCH (2017)
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
Saleh Rachidi et al.
SCIENCE IMMUNOLOGY (2017)
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Petra S. A. Becker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Platelet-Derived Ectosomes Reduce NK Cell Function
Salima Sadallah et al.
JOURNAL OF IMMUNOLOGY (2016)
How to outsmart NK cell tolerance
Grzegorz Terszowski et al.
ONCOIMMUNOLOGY (2015)
The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer
Simon Gebremeskel et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study
Lise J. Estcourt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
KIR/HLA interactions negatively affect rituximab, but not GA101 (obinutuzumab)-induced ADCC
Grzegorz Terszowski et al.
CANCER RESEARCH (2014)
Platelets Effects on Tumor Growth
Hadi A. Goubran et al.
SEMINARS IN ONCOLOGY (2014)
Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein
Laura Amo et al.
FRONTIERS IN ONCOLOGY (2014)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Natural killer cell deficiency
Jordan S. Orange
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Receptor Activator for NF-κB Ligand in Acute Myeloid Leukemia: Expression, Function, and Modulation of NK Cell Immunosurveillance
Benjamin Joachim Schmiedel et al.
JOURNAL OF IMMUNOLOGY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells
Theresa Placke et al.
CANCER RESEARCH (2012)
GITR Ligand Provided by Thrombopoietic Cells Inhibits NK Cell Antitumor Activity
Theresa Placke et al.
JOURNAL OF IMMUNOLOGY (2012)
Platelet granules: surprise packages
Sidney W. Whiteheart
BLOOD (2011)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Platelet-Derived Transforming Growth Factor-β Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
Hans-Georg Kopp et al.
CANCER RESEARCH (2009)
Graft-versus-leukemia effects of transplantation and donor lymphocytes
Hans-Jochem Kolb
BLOOD (2008)
TGF-β utilizes SMAD3 to inhibit CD16-mediated IFN-γ production and antibody-dependent cellular cytotoxicity in human NK cells
Rossana Trotta et al.
JOURNAL OF IMMUNOLOGY (2008)
Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions
Katrin M. Baltz et al.
FASEB JOURNAL (2007)
Donor natural killer cell allorecognition of missing self in haploidentical hernatopoietic transplantation for acute myeloid leukemia: challenging its predictive value
Loredana Ruggeri et al.
BLOOD (2007)
Preoperative thrombocytosis predicts poor survival in patients with glioblastoma
Marc A. Brockmann et al.
NEURO-ONCOLOGY (2007)
Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ
Y Laouar et al.
NATURE IMMUNOLOGY (2005)
Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinorna of the pancreas
KM Brown et al.
AMERICAN JOURNAL OF SURGERY (2005)
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells
JS Palumbo et al.
BLOOD (2005)
Differential expression of thromboxane synthase in prostate carcinoma - Role in tumor cell motility
DT Nie et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
CD107a as a functional marker for the identification of natural killer cell activity
G Alter et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Prognostic significance of thrombocytosis in renal cell carcinoma patients
K Inoue et al.
INTERNATIONAL JOURNAL OF UROLOGY (2004)
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
R Castriconi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Natural killer cell activation receptors in innate immunity to infection
WM Yokoyama et al.
MICROBES AND INFECTION (2002)
Effects of cytarabine and various anthracyclins on platelet activation: Characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemia
B Foss et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
Platelet-leukocyte cross talk in whole blood
NL Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Clinical survival predictors in patients with advanced cancer
A Viganó et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
L Gorelik et al.
IMMUNITY (2000)
Share Paper
